Citation, DOI, disclosures and article data
Citation:
Knipe H, Haouimi A, Focal nodular marrow hyperplasia. Reference article, Radiopaedia.org (Accessed on 11 Jun 2023) https://doi.org/10.53347/rID-147036
Disclosures:
At the time the article was created Henry Knipe had the following disclosures:
- Radiopaedia Events Pty Ltd, Speaker fees (past)
- Integral Diagnostics, Shareholder (ongoing)
- Micro-X Ltd, Shareholder (ongoing)
These were assessed during peer review and were determined to
not be relevant to the changes that were made.
View Henry Knipe's current disclosures
Disclosures:
At the time the article was last revised Henry Knipe had the following disclosures:
- Radiopaedia Events Pty Ltd, Speaker fees (past)
- Integral Diagnostics, Shareholder (ongoing)
- Micro-X Ltd, Shareholder (ongoing)
These were assessed during peer review and were determined to
not be relevant to the changes that were made.
View Henry Knipe's current disclosures
Focal nodular marrow hyperplasia is a rare, benign condition where there is a localized conversion of red/hematopoietic from yellow/fatty bone marrow. Its main relevance is of having a pseudotumor appearance mimicking skeletal metastases on MRI 1.
Location
Most commonly located in the spine (~60%) but can also commonly occur in the femora, sacrum and ilium 2.
Plain radiograph
Focal nodular marrow hyperplasia is occult 3.
CT
Focal nodular marrow hyperplasia can have mild medullary sclerosis but can often appear normal 2,3.
MRI
Focal nodular marrow hyperplasia appears as an ill-defined, solitary or multifocal round-to-oval lesion without marrow edema. The average size is ~20 mm (range 8-55 mm) 1,2.
Signal characteristics
-
T1: iso to mild high signal to skeletal muscle; low signal to marrow
-
T2: low signal compared to skeletal muscle and marrow
-
T2FS/STIR: variable including isointense to yellow marrow
-
T1C+: no enhancement 1-3
Signal intensity drop of >20% between in-phase and out-of-phase quantitative chemical shift imaging (e.g. Dixon method) is shown in most (~90%) cases 2.
Bone scintigraphy
Normal uptake is demonstrated 2.
PET-CT
Focal nodular marrow hyperplasia demonstrates mild increased uptake 2.
-
skeletal metastases: T2 signal tends to be higher, <20% signal drop on chemical shift imaging 2
- 1. Rajakulasingam R & Saifuddin A. Focal Nodular Marrow Hyperplasia: Imaging Features of 53 Cases. Br J Radiol. 2020;93(1112):20200206. doi:10.1259/bjr.20200206 - Pubmed
- 2. Saifuddin A, Tyler P, Rajakulasingam R. Imaging of Bone Marrow Pitfalls with Emphasis on MRI. Br J Radiol. 2022;:20220063. doi:10.1259/bjr.20220063 - Pubmed
- 3. Chow L, Ng A, Wong S. Focal Nodular and Diffuse Haematopoietic Marrow Hyperplasia in Patients with Underlying Malignancies: A Radiological Mimic of Malignancy in Need of Recognition. Clin Radiol. 2017;72(3):265.e7-265.e23. doi:10.1016/j.crad.2016.10.015 - Pubmed
Promoted articles (advertising)